| Product Code: ETC9972187 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, the US continued to see a steady flow of ophthalmology drugs and devices imports from key countries such as Israel, Germany, Japan, Mexico, and Italy. With a low Herfindahl-Hirschman Index (HHI) indicating minimal market concentration, the competitive landscape remains diverse. The compound annual growth rate (CAGR) of 6.86% from 2020 to 2024 reflects a healthy expansion in the market. Although the growth rate slightly slowed in 2024 to 0.41% compared to the previous year, the overall trend suggests a positive outlook for the ophthalmology drugs and devices import market in the US.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Ophthalmology Drugs and Devices Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Ophthalmology Drugs and Devices Market Revenues & Volume, 2022 & 2032F |
3.3 United States (US) Ophthalmology Drugs and Devices Market - Industry Life Cycle |
3.4 United States (US) Ophthalmology Drugs and Devices Market - Porter's Five Forces |
3.5 United States (US) Ophthalmology Drugs and Devices Market Revenues & Volume Share, By Products, 2022 & 2032F |
3.6 United States (US) Ophthalmology Drugs and Devices Market Revenues & Volume Share, By Indication, 2022 & 2032F |
3.7 United States (US) Ophthalmology Drugs and Devices Market Revenues & Volume Share, By End Use, 2022 & 2032F |
4 United States (US) Ophthalmology Drugs and Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of eye diseases and vision impairment |
4.2.2 Technological advancements in ophthalmology drugs and devices |
4.2.3 Growing aging population in the United States |
4.3 Market Restraints |
4.3.1 Stringent regulations for drug approval and device clearance |
4.3.2 High costs associated with ophthalmology drugs and devices |
4.3.3 Limited reimbursement policies for certain treatments |
5 United States (US) Ophthalmology Drugs and Devices Market Trends |
6 United States (US) Ophthalmology Drugs and Devices Market, By Types |
6.1 United States (US) Ophthalmology Drugs and Devices Market, By Products |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Ophthalmology Drugs and Devices Market Revenues & Volume, By Products, 2022 - 2032F |
6.1.3 United States (US) Ophthalmology Drugs and Devices Market Revenues & Volume, By Diagnostic and Monitoring Devices, 2022 - 2032F |
6.1.4 United States (US) Ophthalmology Drugs and Devices Market Revenues & Volume, By Surgical Devices, 2022 - 2032F |
6.1.5 United States (US) Ophthalmology Drugs and Devices Market Revenues & Volume, By Vision Care, 2022 - 2032F |
6.1.6 United States (US) Ophthalmology Drugs and Devices Market Revenues & Volume, By Drugs, 2022 - 2032F |
6.2 United States (US) Ophthalmology Drugs and Devices Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Ophthalmology Drugs and Devices Market Revenues & Volume, By Glaucoma, 2022 - 2032F |
6.2.3 United States (US) Ophthalmology Drugs and Devices Market Revenues & Volume, By Retinal disorders, 2022 - 2032F |
6.2.4 United States (US) Ophthalmology Drugs and Devices Market Revenues & Volume, By Dry eye, 2022 - 2032F |
6.2.5 United States (US) Ophthalmology Drugs and Devices Market Revenues & Volume, By Allergy/Inflammation/Conjunctivitis, 2022 - 2032F |
6.3 United States (US) Ophthalmology Drugs and Devices Market, By End Use |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Ophthalmology Drugs and Devices Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.3.3 United States (US) Ophthalmology Drugs and Devices Market Revenues & Volume, By Clinics, 2022 - 2032F |
6.3.4 United States (US) Ophthalmology Drugs and Devices Market Revenues & Volume, By Others, 2022 - 2032F |
7 United States (US) Ophthalmology Drugs and Devices Market Import-Export Trade Statistics |
7.1 United States (US) Ophthalmology Drugs and Devices Market Export to Major Countries |
7.2 United States (US) Ophthalmology Drugs and Devices Market Imports from Major Countries |
8 United States (US) Ophthalmology Drugs and Devices Market Key Performance Indicators |
8.1 Number of clinical trials for ophthalmology drugs and devices |
8.2 Adoption rate of innovative ophthalmology technologies |
8.3 Patient satisfaction and outcomes following treatments |
9 United States (US) Ophthalmology Drugs and Devices Market - Opportunity Assessment |
9.1 United States (US) Ophthalmology Drugs and Devices Market Opportunity Assessment, By Products, 2022 & 2032F |
9.2 United States (US) Ophthalmology Drugs and Devices Market Opportunity Assessment, By Indication, 2022 & 2032F |
9.3 United States (US) Ophthalmology Drugs and Devices Market Opportunity Assessment, By End Use, 2022 & 2032F |
10 United States (US) Ophthalmology Drugs and Devices Market - Competitive Landscape |
10.1 United States (US) Ophthalmology Drugs and Devices Market Revenue Share, By Companies, 2025 |
10.2 United States (US) Ophthalmology Drugs and Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here